Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DLKW Lowe was a prominent UK-based integrated communications and advertising agency formed in 2010 through the merger of Delaney Lund Knox Warren (DLKW) and Lowe London. Operating as part of the Interpublic Group (IPG), the agency provided a wide range of services including brand strategy, creative advertising, and digital marketing. While a generalist agency, it held a significant portfolio in the healthcare and public health sectors, notably managing major campaigns for the UK National Health Service (NHS), such as 'Change4Life'. In 2016, the agency was rebranded as MullenLowe London following a global realignment of the Mullen and Lowe networks. The firm was recognized for its ability to handle complex, high-budget accounts for both government bodies and global pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DLKW Lowe.